期刊文献+

上海市彭浦社区卫生服务中心高血压监测效果及患者医疗费用研究 被引量:1

Research on the Effectiveness of Surveillance Hypertension Patients and the Patient pay Medical Fees in Shanghai Pengpu Health Service Center
下载PDF
导出
摘要 目的研究彭浦社区卫生服务中心高血压患者实施监测其控制效果及对患者医疗费用的影响。方法在3个级别监测管理的高血压目标对象中随机选择研究对象,以调查表形式进行入户调查,并对2000—2003年社区所有监测管理的高血压患者登记资料进行整理统计。结果一级监测管理目标人群血压控制效果达到50.30%、二级为35.52%、三级为24.81%;一级监测管理人群年人均就诊医疗费用为2016.31元、二级为1556.18元、三级为106.64元;4年的社区高血压监测管理,估计减少患者就诊支付费用达1218206.74元。结论社区高血压监测管理对控制高血压患者病情与并发症的发生、发展起到积极作用,并且减轻患者与国家的疾病经济负担。 OBJECTIVE To Study the control effectiveness of the community hypertension surveillance as well as the influence of hypertension patients medical fees in the Pengpu Community health service center.METHODS The patients were elected randomly from three different management levels and were inquired with questionnaire at home.The data about all the hypertension patientsmanagement level from 2000 to 2003 were arranged and analyzed.RESULTS The control effect of the first level hypertension management is to achieve 50.30%,the second is 35.52%and the third is 24.81%.The average fees of the patients from the first to the third management level are 2 016.31,1 556.18 and 106.64 yuan every year.Due to the comprehensive intervention,it is estimate that the medical fees of hypertension patients could reduce 1 218 206.74yuan in the out patient clinic in 2000—2003.CONCLUSION Hypertension patient surveillance management in community would greatly act to control the state of an illness and the complication of hypertension patients,and can lighten the disease economy burden both the patients and the Nation.
出处 《中国初级卫生保健》 2004年第9期34-36,共3页 Chinese Primary Health Care
关键词 社区高血压患者 监测效果 医疗费用 community hypertension patient,surveillance effectiveness,medical fee
  • 相关文献

参考文献6

二级参考文献18

  • 1全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 2全国血压抽样调查协作组.全国1991年高血压抽样调查实施中的质量控制[J].高血压杂志,1995,3(A01):2-7. 被引量:7
  • 3吴锡桂,武阳丰,周北凡,陶寿淇,沈丽卿,王淑玉,朱树雄,徐祥林,杨瑞祥,杜福昌,王益琏,何厚琦,夏舜英,阮连生.我国十组人群高血压发病率及其影响因素[J].中华医学杂志,1996,76(1):24-29. 被引量:147
  • 4[1]Wilhelmsen L,Berglund G,Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden[J]. European Heart Journal, 1986,7∶279-288. 被引量:1
  • 5[2]Jacobs DR, Lupker RV, Mittelmark MB, et al. Community-wide prevention strategies. Evaluation design of the Minnesota Heart Health Progran[J]. J Chronic Dis, 1986,39∶775-788. 被引量:1
  • 6[3]WHO European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-yera result [J]. Lancet, 1986,1∶869-872. 被引量:1
  • 7[4]The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High blood Pressure (JNC V) [J]. Arch Intern Med, 1993, 153(1)∶154-183. 被引量:1
  • 8[5]Mac Mahon S, Podgers A. Blood pressure, antihypertensive treatment and stroke risk[J]. J Hypertens, 1994,12(10)∶S5-14. 被引量:1
  • 9[6]Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia [J]. Lancet, 1998, 352(9143)∶1801-1807. 被引量:1
  • 10[7]Ambrosioni E, Bacchelli S.Clinical approach to the hypertensive patient. New guidelines[J]. Ann Ital Med Int, 1998,13(1)∶30-36. 被引量:1

共引文献1029

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部